Market research
300006.SHE Chongqing Lummy Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5B
- P/E ratio
- Not available
- Analyst target
- 10.78
- Dividend yield
- Not available
- Beta
- 0.43
Community
Investor discussion
1 comment
Sign in to join the 300006.SHE discussion.
5 years, 5 months ago
Chongqing Lummy Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 1.3% above its 200 day moving average.
From a valuation standpoint, the stock is 69.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Chongqing Lummy Pharmaceutical Co., Ltd's total revenue sank by 8.6% to $512M since the same quarter in the previous year.
Its net income has dropped by 41.5% to $-327M since the same quarter in the previous year.
Finally, its free cash flow fell by 109.1% to $-8M since the same quarter in the previous year.
Based on the above factors, Chongqing Lummy Pharmaceutical Co., Ltd gets an overall score of 2/5.